102 related articles for article (PubMed ID: 36600099)
21. 68Ga-chloride PET reveals human pancreatic adenocarcinoma xenografts in rats--comparison with FDG.
Ujula T; Salomäki S; Autio A; Luoto P; Tolvanen T; Lehikoinen P; Viljanen T; Sipilä H; Härkönen P; Roivainen A
Mol Imaging Biol; 2010 Jun; 12(3):259-68. PubMed ID: 19798536
[TBL] [Abstract][Full Text] [Related]
22. Imaging findings and clinical relevance of
Wang M; Zhang J; Ma J; Liu L; Wang J; Zhang C
BMC Med Imaging; 2023 Oct; 23(1):166. PubMed ID: 37884885
[TBL] [Abstract][Full Text] [Related]
23. Translational PET Imaging of Nectin-4 Expression in Multiple Different Cancers with
Zhang J; Duan X; Chen X; Zhang Z; Sun H; Shou J; Zhao G; Wang J; Ma Y; Yang Y; Tian X; Shen Q; Yu W; He Z; Fan Y; Yang X
J Nucl Med; 2024 May; 65(Suppl 1):12S-18S. PubMed ID: 38719240
[TBL] [Abstract][Full Text] [Related]
24. 18 F-FDG PET/CT in a Case of Clear Cell Sarcoma of the Kidney.
Jin H; Yin Y; Wang H; Cheng W
Clin Nucl Med; 2024 May; 49(5):468-469. PubMed ID: 38377388
[TBL] [Abstract][Full Text] [Related]
25. First-in-human evaluation of [
Silins I; Sundin A; Lubberink M; O'Sullivan L; Gurnell M; Aigbirhio F; Brown M; Wall A; Åkerström T; Roslin S; Hellman P; Antoni G
Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):398-409. PubMed ID: 36074157
[TBL] [Abstract][Full Text] [Related]
26. Potential Efficacy of 68Ga-Trivehexin PET/CT and Immunohistochemical Validation of αvβ6 Integrin Expression in Patients With Head and Neck Squamous Cell Carcinoma and Pancreatic Ductal Adenocarcinoma.
Das SS; Ahlawat S; Thakral P; Malik D; Simecek J; Cb V; Koley M; Gupta J; Sen I
Clin Nucl Med; 2024 May; ():. PubMed ID: 38768077
[TBL] [Abstract][Full Text] [Related]
27. 18 F-FDG PET/CT in Renal Allograft Tuberculosis Mimicking as Posttransplant Malignancy.
Moideen A; Singh H; Kumar R; Naik SM; Gupta A; Sekar A; Nada R
Clin Nucl Med; 2024 Feb; 49(2):e52-e53. PubMed ID: 38049975
[TBL] [Abstract][Full Text] [Related]
28. A CAIX Dual-Targeting Small-Molecule Probe for Noninvasive Imaging of ccRCC.
He C; Liu F; Tao J; Wang Z; Liu J; Liu S; Xu X; Li L; Wang F; Yang X; Zhu H; Yang Z
Mol Pharm; 2024 Jun; ():. PubMed ID: 38831541
[TBL] [Abstract][Full Text] [Related]
29.
Lagerveld BW; Sivro F; van der Zee JA; Baars PC
J Kidney Cancer VHL; 2015; 2(4):174-186. PubMed ID: 28326272
[TBL] [Abstract][Full Text] [Related]
30. Differential tumor biology between locoregional and distant metastasis in a patient with TENIS with TKI-resistant aggressive recurrent disease: a comparative evaluation with FDG,
Sonavane SN; Basu S
J Nucl Med Technol; 2021 Dec; ():. PubMed ID: 34872919
[TBL] [Abstract][Full Text] [Related]
31. Sensitivity of pretargeted immunoPET using
Foubert F; Gouard S; Saï-Maurel C; Chérel M; Faivre-Chauvet A; Goldenberg DM; Barbet J; Bailly C; Bodet-Milin C; Carlier T; Kraeber-Bodéré F; Touchefeu Y; Frampas E
Oncotarget; 2018 Jun; 9(44):27502-27513. PubMed ID: 29938001
[TBL] [Abstract][Full Text] [Related]
32. Oligometastatic Renal Cell Carcinoma With Sarcomatoid Differentiation Demonstrating Variable Imaging Phenotypes on
Nadebaum DP; Hofman MS; Mitchell CA; Siva S; Hicks RJ
Clin Genitourin Cancer; 2017 Aug; ():. PubMed ID: 28890070
[No Abstract] [Full Text] [Related]
33. Correlation between Kidney Uptake at [18F]FDG PET/CT and Renal Function.
Dondi F; Pisani AR; Lucarelli NM; Gazzilli M; Talin A; Albano D; Rubini D; Maggialetti N; Rubini G; Bertagna F
J Pers Med; 2023 Dec; 14(1):. PubMed ID: 38248741
[TBL] [Abstract][Full Text] [Related]
34. First-in-Human Safety, Imaging, and Dosimetry of a Carbonic Anhydrase IX-Targeting Peptide, [
Hofman MS; Tran B; Feldman DR; Pokorska-Bocci A; Pichereau S; Wessen J; Haskali MB; Sparks RB; Vlasyuk O; Galetic I
J Nucl Med; 2024 Feb; 65(5):740-3. PubMed ID: 38388517
[TBL] [Abstract][Full Text] [Related]
35. Standardized classification schemes in reporting oncologic PET/CT.
Murad V; Kulanthaivelu R; Ortega C; Veit-Haibach P; Metser U
Front Med (Lausanne); 2022; 9():1051309. PubMed ID: 36777163
[TBL] [Abstract][Full Text] [Related]
36. Association between CT-based adipose variables, preoperative blood biochemical indicators and pathological T stage of clear cell renal cell carcinoma.
Sun Z; Zhang Y; Xia Y; Ba X; Zheng Q; Liu J; Kuang X; Xie H; Gong P; Shi Y; Mao N; Wang Y; Liu M; Ran C; Wang C; Wang X; Li M; Zhang W; Fang Z; Liu W; Guo H; Ma H; Song Y
Heliyon; 2024 Jan; 10(2):e24456. PubMed ID: 38268833
[TBL] [Abstract][Full Text] [Related]
37. Correction to: One‑stop [
Liu G; Mao W; Yu H; Hu Y; Gu J; Shi H
Eur J Nucl Med Mol Imaging; 2023 Aug; 50(10):3159. PubMed ID: 37391546
[No Abstract] [Full Text] [Related]
38. Leukemoid reaction with
Reguera Berenguer L; Pérez Pascual R; García García JF; de Santiago García J; Márquez Vázquez R; Alonso Farto JC
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020 Oct; ():. PubMed ID: 33071175
[No Abstract] [Full Text] [Related]
39. A prospective head-to-head comparison of [
Wang G; Li L; Zhu M; Zang J; Wang J; Wang R; Yan W; Zhu L; Kung HF; Zhu Z
Eur J Nucl Med Mol Imaging; 2023 Aug; 50(10):3126-3136. PubMed ID: 37233785
[TBL] [Abstract][Full Text] [Related]
40. Head-to-Head Comparison of 68 Ga-P16-093 and 68 Ga-PSMA-617 PET/CT in Patients With Primary Prostate Cancer : A Pilot Study.
Wang G; Li L; Zang J; Hong H; Zhu L; Kung HF; Zhu Z
Clin Nucl Med; 2023 Apr; 48(4):289-295. PubMed ID: 36727866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
